Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
February 2016

Drugs for Dementia
Current medications for dementia do little to improve cognition or function.

Two New Long-Acting IM Antipsychotics
Aripiprazole lauroxil (Aristada) and a 3-month formulation of paliperidone palmitate (Invega Trinza) have been approved for the treatment of schizophrenia.

Exercise for Late-Life MDD
In a study of older patients with major depressive disorder, both high- and low-intensity exercise added to antidepressant treatment improved remission rates and time to remission.

In Brief
Offspring of Mothers with Polycystic Ovary Syndrome Have Increased Risk of Autism; Androgen Deprivation Therapy Linked to Increased Risk of Alzheimer Disease

A Drug Combination for Agitation in Dementia
In a multicenter trial, the combination of dextromethorphan and quinidine sulfate (Nuedexta) was statistically superior to placebo as a treatment for agitation in patients with Alzheimer disease.

Download a Sample Issue of BTP

A following sample issue of Biological Therapies in Psychiatry is available in .pdf format. These files require Adobe Acrobat© Reader to view. (If you do not currently have the Acrobat Reader, click here to download).

Download a free sample pdf of BTP



One, two and three-year subscriptions are immediately available. Each subscription allows you full online access to current and recent issues, a searchable online database, downloadable audio files, and a printed newsletter that will be mailed to you monthly. You'll receive timely, accurate information at a very reasonable price. A one-year US subscription is only $90.00.


Subscribe